ArticleEvidence-based medicine2012

Hydroxycarbamide for very young children with sickle cell anaemia: no effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity.

Deepa ManwaniPubMed ↗Publisher ↗

No numbers read from the abstract.